Impact of Enhanced Phagocytosis of Glycated Erythrocytes on Human Endothelial Cell Functions

Cells. 2022 Jul 14;11(14):2200. doi: 10.3390/cells11142200.

Abstract

Diabetes is associated with a high mortality rate due to vascular complications. Chronic hyperglycemia in diabetes leads to enhanced oxidative stress and glycation. Here, we explored the impact of glycation on human erythrocyte characteristics and capacity to affect endothelial cell function following erythrophagocytosis. Native and glucose-mediated glycated erythrocytes were prepared and characterized in terms of structural and deformability modifications. Erythrocyte preparations were tested for their binding and phagocytosis capacity as well as the potential functional consequences on human endothelial cell lines and primary cultures. Oxidative modifications were found to be enhanced in glycated erythrocytes after determination of their deformability, advanced glycation end-product content and eryptosis. Erythrophagocytosis by endothelial cells was significantly increased when incubated in the presence of glycated erythrocytes. In addition, higher iron accumulation, oxidative stress and impaired endothelial cell permeability were evidenced in cells previously incubated with glycated erythrocytes. When cultured under flow conditions, cellular integrity was disrupted by glycated erythrocytes at microvessel bifurcations, areas particularly prone to vascular complications. This study provides important new data on the impact of glycation on the structure of erythrocytes and their ability to alter endothelial cell function. Increased erythrophagocytosis may have a deleterious impact on endothelial cell function with adverse consequences on diabetic vascular complications.

Keywords: diabetes; endothelial cells; erythrocytes; erythrophagocytosis; glycation; oxidative stress; red blood cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus* / metabolism
  • Endothelial Cells* / metabolism
  • Erythrocytes / metabolism
  • Glycation End Products, Advanced / metabolism
  • Humans
  • Phagocytosis / physiology

Substances

  • Glycation End Products, Advanced

Grants and funding

This work was supported by the Ministère de l’Enseignement Supérieur et de la Recherche, La Réunion University and by the European Regional Development Funds RE0001897 (EU, Région Réunion, French State national counterpart). It has also been partially supported by “Agencia Estatal de Investigación, Ministerio de Economía y Competitividad” (Spain) under contract RTI2018-097063-B-100, and “Sociedad Española de Cardiología y Fundación Española del Corazón” under contract SEC/FEC-INV-BAS 20/013. CT was a recipient of a fellowship grant from the Ministère de l’Enseignement Supérieur et de la Recherche, La Réunion University. B. Carnero thanks GAIN/Xunta de Galicia for the contract under N°. 11_IN606D_2021_2604925. A. Muñuzuri thanks Xunta de Galicia for the Research Grant N°2021-PG036. M.Flores-Arias thanks Xunta de Galicia for the Research Grant N°ED431B 2020/29.